Q87.19 Other congenital malformation syndromes predominantly associated with short statureBillable ICD-10-CM code, FY2026. Acts as a Complication or Comorbidity (CC) as a secondary diagnosis. Exempt from present-on-admission (POA) reporting.
Defines the logic of DRG(s) 564-566 in MDC 08.
E23.3 Hypothalamic dysfunction, not elsewhere classified ("Russell-Silver syndrome (Q87.19)")E34.3 Short stature due to endocrine disorder ("Russell-Silver syndrome (Q87.19)")E79 Disorders of purine and pyrimidine metabolism ("Ataxia-telangiectasia (Q87.19)")E79 Disorders of purine and pyrimidine metabolism ("Cockayne's syndrome (Q87.19)")G11.3 Cerebellar ataxia with defective DNA repair ("Cockayne's syndrome (Q87.19)")Q81.0 Epidermolysis bullosa simplex ("Cockayne's syndrome (Q87.19)")Q96 Turner's syndrome ("Noonan syndrome (Q87.19)")Q67 Congenital musculoskeletal deformities of head, face, spine and chest ("congenital malformation syndromes classified to Q87.-")Q75 Other congenital malformations of skull and face bones ("congenital malformation syndromes classified to Q87.-")Q89.7 Multiple congenital malformations, not elsewhere classified ("congenital malformation syndromes affecting multiple systems (Q87.-)")Q87 Other specified congenital malformation syndromes affecting multiple systemsQ87.0 Congenital malformation syndromes predominantly affecting facial appearanceQ87.1 Congenital malformation syndromes predominantly associated with short statureQ87.11 Prader-Willi syndromeQ87.19 Other congenital malformation syndromes predominantly associated with short stature (this code)Q87.2 Congenital malformation syndromes predominantly involving limbsQ87.3 Congenital malformation syndromes involving early overgrowthQ87.4 Marfan syndromeQ87.40 Marfan syndrome, unspecifiedQ87.41 Marfan syndrome with cardiovascular manifestations